News

Business Wire2y
Enanta Pharmaceuticals Presents Preclinical Data for its Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Programs at the 12 th International RSV Symposium
Additional posters characterize a 3D culture model ... a Novel L-Protein Inhibitor for the Treatment of Respiratory Syncytial Virus,” Michael Rhodin, Ph.D., United States In a preclinical ...
Nasdaq2y
Enanta Pharmaceuticals Presents Preclinical Data for its Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Programs at the 12th International RSV Symposium
Additional posters characterize a 3D culture model ... “EDP-323, a Novel L-Protein Inhibitor for the Treatment of Respiratory Syncytial Virus,” Michael Rhodin, Ph.D., United States In a ...